322 related articles for article (PubMed ID: 19675450)
41. Papillary lesions of the breast: a review.
Mulligan AM; O'Malley FP
Adv Anat Pathol; 2007 Mar; 14(2):108-19. PubMed ID: 17471117
[TBL] [Abstract][Full Text] [Related]
42. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.
Jaffer S; Nagi C; Bleiweiss IJ
Cancer; 2009 Jul; 115(13):2837-43. PubMed ID: 19402174
[TBL] [Abstract][Full Text] [Related]
43. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up.
Bernik SF; Troob S; Ying BL; Simpson SA; Axelrod DM; Siegel B; Moncrief RM; Mills C; Aziz M
Am J Surg; 2009 Apr; 197(4):473-8. PubMed ID: 18723154
[TBL] [Abstract][Full Text] [Related]
44. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
45. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Vassallo J; Alvarenga M
Breast J; 2008; 14(1):68-75. PubMed ID: 18086274
[TBL] [Abstract][Full Text] [Related]
46. Breast pathology practice: most common problems in a consultation service.
Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
[TBL] [Abstract][Full Text] [Related]
47. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
[TBL] [Abstract][Full Text] [Related]
48. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
[TBL] [Abstract][Full Text] [Related]
49. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2009 Sep; 50(7):722-9. PubMed ID: 19488890
[TBL] [Abstract][Full Text] [Related]
50. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
Eby PR; Ochsner JE; DeMartini WB; Allison KH; Peacock S; Lehman CD
Ann Surg Oncol; 2008 Nov; 15(11):3232-8. PubMed ID: 18696163
[TBL] [Abstract][Full Text] [Related]
51. The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology.
Reisenbichler ES; Ross JR; Hameed O
Ann Diagn Pathol; 2014 Dec; 18(6):313-8. PubMed ID: 25224390
[TBL] [Abstract][Full Text] [Related]
52. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
Richter-Ehrenstein C; Müller S; Noske A; Schneider A
Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy.
Arora N; Hill C; Hoda SA; Rosenblatt R; Pigalarga R; Tousimis EA
Am J Surg; 2007 Oct; 194(4):444-9. PubMed ID: 17826053
[TBL] [Abstract][Full Text] [Related]
55. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
56. Micropapillary carcinoma of the breast with necrosis-like cell death: a case report.
Caruso RA; Cicciarello R; Gagliardi ME; Albiero F; Costa G; Fedele F; Cavaliere R; Finocchiaro G; Mesiti M; Cavallari V
Ultrastruct Pathol; 2008; 32(4):153-9. PubMed ID: 18696401
[TBL] [Abstract][Full Text] [Related]
57. Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note.
Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Terasaki H; Nomura Y; Takenaka M; Naito Y; Akiba J; Yano H
J Clin Pathol; 2014 Mar; 67(3):258-62. PubMed ID: 24062357
[TBL] [Abstract][Full Text] [Related]
58. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma.
Goldstein NS; Ferkowicz M; Odish E; Mani A; Hastah F
Am J Clin Pathol; 2003 Jul; 120(1):86-92. PubMed ID: 12866377
[TBL] [Abstract][Full Text] [Related]
59. Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis?
Tse GM; Ma TK; Lui PC; Ng DC; Yu AM; Vong JS; Niu Y; Chaiwun B; Lam WW; Tan PH
J Clin Pathol; 2008 Aug; 61(8):945-9. PubMed ID: 18552172
[TBL] [Abstract][Full Text] [Related]
60. [Morphologic evaluation of papillary carcinoma of the breast featuring expansile invasion].
Yang GZ; Li J; Jin H; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):81-5. PubMed ID: 23710912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
